Clinical trial
Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib Following Impacted Third Molar Surgery
NCT05142098 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib Following Impacted Third Molar Surgery
- Lead sponsor
- Dow University of Health Sciences
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- August 1, 2022
- Enrollment
- 170 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
effect of drug